
[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Page 40704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14722]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-D-1543]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Guidance for Industry 
on Nonproprietary Naming of Biological Products; Withdrawal

AGENCY: Food and Drug Administration, HHS.

ACTION: Withdrawal of notice.

-----------------------------------------------------------------------

SUMMARY: This document withdraws a Food and Drug Administration (FDA) 
notice that published in the Federal Register of June 2, 2016 (81 FR 
35367).

DATES: This notice is withdrawn on June 22, 2016.

FOR FURTHER INFORMATION CONTACT: Howard Muller, Center for Drug 
Evaluation and Research (CDER), 10903 New Hampshire Ave., Bldg. 51, Rm. 
6234, Silver Spring, MD 20993-0002, 301-796-3474.

SUPPLEMENTARY INFORMATION: FDA published a notice in the Federal 
Register of June 2, 2016, informing interested parties that the 
proposed collection of information entitled ``Guidance for Industry on 
Nonproprietary Naming of Biological Products'' had been submitted to 
the Office of Management and Budget (OMB) for review and clearance 
under the Paperwork Reduction Act of 1995 and inviting the public to 
submit comments on the proposed collection to OMB. FDA is withdrawing 
the proposed collection of information that published on June 2, 2016, 
at this time.

    Dated: June 16, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-14722 Filed 6-21-16; 8:45 am]
 BILLING CODE 4164-01-P


